Analysts at Credit Suisse upgraded shares of Goldcorp Inc. (USA) (NYSE:GG) from a “neutral” rating to an “outperform” rating in a research note on Thursday, March 13th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Goldcorp Inc. (USA) (NYSE:GG) in a research note on Thursday, March 6th. Goldcorp Inc. (USA) (NYSE:GG) stock…
Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) wants to start life with a new slate. It has taken several measures to wipe out the old issues. The company took care of two major worries. Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) stock performance was 10.43% in last session and finished the day at $5.93. Traded volume was 1.14 million…
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) presented an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California. Biota Pharmaceuticals Inc (NASDAQ:BOTA) stock performance was 10.15% in last session and finished the day at $6.62. Traded volume was 449,674 million shares in the…
Johnson & Johnson (NYSE:JNJ) is an undisputed global leader in the health care industry, benefiting from a rock-solid competitive position in areas such as medical devices and several pharmaceutical markets. Growing health care demand due to an aging population, broadened health insurance coverage, and technological advancements in the industry bode well for Johnson & Johnson…
Advanced Micro Devices (NYSE:AMD) was upgraded by stock analysts at TheStreet from a “sell” rating to a “hold” rating in a report issued on Wednesday, American Banking and Market News reports. Advanced Micro Devices, Inc. (NYSE:AMD) stock performance was -0.25% in last session and finished the day at $4.04. Traded volume was 23.99million shares in…
Celgene Corp (NASDAQ:CELG) was unchanged in Friday’s after-market and the biotech company confirmed the U.S. Food and Drug Administration has approved the company’s psoriatic arthritis treatment, the first of its kind in this country. The drug will be marketed commercially as Otezla. According to the company, the drug works differently than other approved therapies through…
